English | 中文版 | 手机版 企业登录 | 个人登录 | 邮件订阅
生物器材网 logo
HD5000AI多谱超分辨菌落成像系统
当前位置 > 首页 > 行业资讯 > 新闻 > Exosome研究成果荣获2014年美国肝病会议总统奖

Exosome研究成果荣获2014年美国肝病会议总统奖

浏览次数:3718 发布日期:2014-11-14  来源:本站 本站原创,转载请注明出处
Exosome研究成果《MicroRNA profiling of circulating exosomes during experimental liver fibrosis》荣获2014年美国肝病会议总统奖
 
大家期待已久的101Bio的PureExo Exosome Isolation Kits客户使用的文章即将见刊。
 
美国Nationwide Childrens Hospital和The Ohio State University的研究团队使用美国101Bio的PureExo Exosome Isolation Kits从血清中分离出高纯的exosome,并开展了下游的研究工作。共同完成文章《MicroRNA profiling of circulating exosomes during experimental liver fibrosis》。该文章摘要投到2014年的美国肝病会议(AASLD)后,被授予了总统奖(Presidential honor),并刊登在这一期的肝脏病杂志(《Hepatology》)上:http://onlinelibrary.wiley.com/doi/10.1002/hep.27500/pdf(请见Abstract #430),正式文章也将在该杂志发表。
MicroRNA profiling of circulating exosomes during experimental liver fibrosis
Li Chen1, Ruju Chen1, David Brigstock1,2;
1Clinical & Translational Research, Nationwide Childrens Hospital, Columbus, OH; 2Surgery, The Ohio State University, Columbus, OH
 
Background: Exosomes arise by inward budding of the limiting membranes of multivesicular bodies which, upon fusion with the plasma membrane, result in their secretion and deposition into body fluids (e.g. blood, urine). Exosomes contain a complex mixture of microRNAs (miRs), mRNAs and proteins that reflect the transcriptional and translational status of the producer cell. Since this molecular payload is a “fingerprint” of the dynamic status of their producer cells, exosomes represent a potentially valuable resource for assessing liver disease or pathology. Our goal was to profile the microRNA content of serum exosomes in experimental liver fibrosis. Methods: PureExo Exosome Isolation Kits were used to isolate serum exosomes. MiR profiling was performed on exosomal RNA from 1ml of pooled serum (5 mice; 200μl/mouse) using a mouse miRnome miR PCR Array. miR profiling was performed for the 940 best characterized miRs in the mouse miRnome on exosomes isolated from the circulation of mice after 1 or 5 weeks of treatment with CCl4, as compared to oil-treated controls, with liver injury/fibrosis confirmed histologically. Differentially expressed miRs were confirmed and/or further evaluated by qRT-PCR of exosomal RNA independently obtained at 1-, 4- or 5-weeks of CCl4 administration (n=5). Results: Isolated exosomes from mice serum were bi-membrane vesicles, 50-200nm in diameter, and positive for the exosome markers, CD9 and flotillin-1. Microarray analysis revealed significant alterations in the expression of many hundreds of miRs after either 1- or 5-wks of CCl4 treatment as compared to their respective oil controls. We then focused on selected miRs previously reported to be altered in fibrotic liver, and confirmed the data by RT-PCR. The exosomal levels of these miRs after 5 weeks of CCl4 (including up-regulation of miR-7a, -21, -22, -24, -34a, -155, or -195, and down-regulation of miR-27a, -192, -214, or -377) reflected their previously documented changes at the tissue level in fibrotic liver. In addition, several exosomal miRs that have not yet to be reported in the literature as being altered during liver fibrosis emerged as potentially novel fibrosis markers (e.g. up-regulation of miR-26b or -122; down-regulation of miR-9 or -196b). As compared to their levels at 5 weeks, many of these miRs exhibited individually distinct patterns of expression during the course of fibrosis progression. Conclusions: Dynamic changes occur in the miR content of circulating exosomes during experimental hepatic fibrosis supporting the concept that fibrosis progression and severity is amenable to minimally-invasive assessment through determination of signature exosomal miRs.
 
相关产品
中英文品名
品牌
货号
规格
PureExo® Exosome Isolation Kit (for cell culture media) #P100
101Bio
P100
10rxns
101Bio
P100S
2rxns
101Bio
P100L
40rxns
PureExo® Exosome Isolation Kit (for serum and plasma) #P101
101Bio
P101
10rxns
101Bio
P101S
2rxns
101Bio
P101L
40rxns
DiagExo® Urinary Exosome Isolation Kit #P120
101Bio
P120
20rxns
DiagExo® Human Body Fluid Exosome Isolation kit #P121
101Bio
P121
20rxns
Exosomal RNA and Protein Extraction Kit #P200
101Bio
P200
20rxns
DiagExo® Serum Exosomal Protein Extraction kit
101Bio
P300
10rxns
101Bio
P300S
2rxns
ExoFectin® sRNA-into-Exosome Kit (Electro) #P400
101Bio
P400
10rxns
101Bio
P400S
2rxns
ExoFectin® sRNA-into-Exosome Kit (Chemical) #P401
101Bio
P401
20rxns
101Bio
P401S
4rxns
 
西美杰代理的美国101Bio的系列Exosome分离试剂盒(PureExo® Exosome Isolation Kit/ DiagExo® Urinary Exosome Isolation Kit/ DiagExo® Human Body Fluid Exosome Isolation kit),可从细胞培养基、血清、尿液或体液中富集大量完整的外泌体。试剂盒具有如下特点:
 
● 方便——无需超速离心;
快捷——不到2个小时即可完成外切体分离纯化;
高回收率——是超速离心的5~10倍;
高纯度——所得外切体纯度高达95% 以上。
 
欢迎致电北京西美杰科技有限公司400-050-4006了解更多信息。
相关公司:北京西美杰科技有限公司
联系电话:4000-50-4006,010-88597838,021-63599871/72(上海分公司)
E-mail:info@xmjsci.com


高端的生物技术和制药加工设备
用户名: 密码: 匿名 快速注册 忘记密码
评论只代表网友观点,不代表本站观点。 请输入验证码: 8795
Copyright(C) 1998-2026 生物器材网 电话:021-64166852;13621656896 E-mail:info@bio-equip.com